ALOGLIPTIN-METFORMIN 12.5-500

alogliptin and metformin hydrochloride
$2.1623per EA

Strength

12.5; 500 mg/1; mg/1

NDC

45802016972

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA203414

On Market Since

4/8/2016

Pharmacological Classes

Biguanide
Biguanides
Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price History

1W

0.0%

1M

-0.7%

3M

-5.3%

6M

-7.0%

1Y

-11.6%

3Y

-13.4%

5Y

-1.9%

All

-27.9%